Related Experiment Video
Updated: May 5, 2026

An In Vitro Bladder Model of Catheter-Associated Urinary Tract Infection
Published on: June 24, 2025
Vancomycin resistant enterococci healthcare associated infections
1Department of Public Health and Infectious Diseases, Sapienza University of Rome, Italy.
Vancomycin-resistant enterococci (VRE) infections are a significant healthcare concern, leading to higher mortality and economic costs. Implementing strict infection control measures is crucial to reduce VRE spread in healthcare settings.
Area of Science:
- Infectious Diseases
- Microbiology
- Public Health
Background:
- Vancomycin-resistant enterococci (VRE) are prevalent multidrug-resistant organisms in healthcare settings.
- VRE poses a significant challenge due to its increasing prevalence and resistance to multiple antibiotics.
Purpose of the Study:
- To review current epidemiological data on VRE.
- To discuss clinical implications and challenges associated with VRE infections.
- To outline effective infection control strategies for VRE.
Main Methods:
- A comprehensive literature search was conducted using PubMed-MEDLINE.
- Data on VRE prevalence, clinical outcomes, and control measures were synthesized.
Main Results:
- VRE prevalence varies significantly across European countries and North America, with some regions showing high rates.
- VRE infections are associated with increased mortality (over two-fold) and higher economic burden compared to vancomycin-susceptible enterococci (VSE).
- Emerging resistance to newer agents like daptomycin and linezolid complicates treatment options.
Conclusions:
- Effective VRE control requires multifaceted strategies including hand hygiene, surveillance cultures, and contact isolation.
- Antimicrobial stewardship programs are essential to manage VRE effectively.
- Reducing VRE colonization and infection incidence is critical in healthcare environments.
Related Concept Videos
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Clinical Significance of Antibiotic Resistance
Endocarditis I: Introduction
Mechanism of Antibiotic Resistance in MRSA
Staphylococcal Skin Infections

